The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wang Theodore T since 2018.
This trader's CIK number is 1694061.
At the time of last reporting, Wang Theodore T was the 10% Owner of Bellerophon Therapeutics, Inc.. (stock ticker symbol BLPH).
Also see all insider trading activities at Bellerophon Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | TCON | 0 | $0 | 384,130 | $1,127,378 | 0 | $0 |
| 2018 | TCON | 4,326 | $4,888 | 4,326 | $5,234 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | BLPH | 0 | $0 | 1,211,262 | $223,560 | 0 | $0 |
| 2020 | BLPH | 7,586 | $96,895 | 0 | $0 | 0 | $0 |
| 2019 | BLPH | 579,223 | $393,027 | 0 | $0 | 0 | $0 |
1. Tracon Pharmaceuticals, Inc. (TCON)
2. Bellerophon Therapeutics, Inc. (BLPH)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-12-09 | TCON | Sale | 340,134 | 2.92 | 993,191 |
| 2019-12-05 | TCON | Sale | 43,996 | 3.05 | 134,187 |
| 2018-11-29 | TCON | Buy | 4,326 | 1.13 | 4,888 |
| 2018-11-29 | TCON | Sale | 4,326 | 1.21 | 5,234 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-10-13 | BLPH | Sale | 1,076,841 | .10 | 111,991 |
| 2023-06-07 | BLPH | Sale | 134,421 | .83 | 111,569 |
| 2020-06-05 | BLPH | Buy | 4,986 | 12.72 | 63,441 |
| 2020-06-08 | BLPH | Buy | 2,600 | 12.87 | 33,454 |
| 2019-11-21 | BLPH | Buy | 200 | .37 | 74 |
| 2019-11-22 | BLPH | Buy | 1,050 | .38 | 393 |
| 2019-11-25 | BLPH | Buy | 7,193 | .39 | 2,776 |
| 2019-06-12 | BLPH | Buy | 50,000 | .64 | 31,900 |
| 2019-05-22 | BLPH | Buy | 27,500 | .60 | 16,527 |
| 2019-05-21 | BLPH | Buy | 43,280 | .61 | 26,357 |
| 2019-01-25 | BLPH | Buy | 450,000 | .70 | 315,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wang Theodore T (10% Owner of Bellerophon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.